Ameritas Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ameritas Advisory Services’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+2,571	New	+$232K	0.01%	1007
2025 Q4	–	Sell	-1,220	Closed	-$88.5K	–	1505
2025 Q3	$88.5K	Sell	1,220 -1,354	-53%	-$93.4K	0.01%	883
2025 Q2	$169K	Buy	+2,574	New	+$168K	0.01%	795
2023 Q2	–	Sell	-1,155	Closed	-$67.7K	–	1516
2023 Q1	$67.7K	Buy	+1,155	New	+$69.6K	﹤0.01%	1146

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Ameritas Advisory Services's IHE Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 2,571 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #1007 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in IHE as recently as Q3 2025.

Ameritas Advisory Services first reported a position in IHE in Q1 2023 and has held it in 4 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Ameritas Advisory Services held 2,571 shares of iShares US Pharmaceuticals ETF worth $255K as of Q2 2026.
iShares US Pharmaceuticals ETF was a new Ameritas Advisory Services position in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1007 holding.
Ameritas Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q1 2023 and has held it in 4 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.